{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:43:33Z","timestamp":1753875813185,"version":"3.41.2"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T00:00:00Z","timestamp":1617580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602620","81803431","81700540","81830054","91859205","81988101","82073307"],"award-info":[{"award-number":["81602620","81803431","81700540","81830054","91859205","81988101","82073307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Education Commission","award":["201901070007E00065"],"award-info":[{"award-number":["201901070007E00065"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>It is pivotal and remains challenge for cancer precision treatment to identify the survival outcome interactions between genes, cells and drugs. Here, we present siGCD, a web-based tool for analysis and visualization of the survival interaction of Genes, Cells and Drugs in human cancers. siGCD utilizes the cancer heterogeneity to simulate the manipulated gene expression, cell infiltration and drug treatment, which overcomes the data and experimental limitations. To illustrate the performance of siGCD, we identified the survival interaction partners of EGFR (gene level), T cells (cell level) and sorafenib (drug level), and our prediction was consistent with previous reports. Moreover, we validate the synergistic effect of regorafenib and glyburide, and found that glyburide could significantly improve the regorafenib response. These results demonstrate that siGCD could benefit cancer precision medicine in a wide range of advantageous application scenarios including gene regulatory network construction, immune cell regulatory gene identification, drug (especially multiple target drugs) response biomarker screening and combination therapeutic design.<\/jats:p>","DOI":"10.1093\/bib\/bbab058","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T20:10:15Z","timestamp":1616616615000},"source":"Crossref","is-referenced-by-count":2,"title":["siGCD: a web server to explore survival interaction of genes, cells and drugs in human cancers"],"prefix":"10.1093","volume":"22","author":[{"given":"XiuLiang","family":"Cui","sequence":"first","affiliation":[{"name":"National Center for Liver Cancer, the Second Military Medical University, Shanghai 200438, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"},{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute for Hepatology, The Second Affiliated Hospital, South University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen 518112, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, Shanghai 200438, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Sun","sequence":"additional","affiliation":[{"name":"National Center for Liver Cancer, the Second Military Medical University, Shanghai 200438, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200438, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"},{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"},{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Wang","sequence":"additional","affiliation":[{"name":"National Center for Liver Cancer, the Second Military Medical University, Shanghai 200438, China"},{"name":"International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital\/Institute, the Second Military Medical University, 200438, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,4,5]]},"reference":[{"key":"2021090815235816600_ref1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2014.11.025","article-title":"14-3-3zeta turns TGF-beta's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2","volume":"27","author":"Xu","year":"2015","journal-title":"Cancer Cell"},{"key":"2021090815235816600_ref2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"2021090815235816600_ref3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2021090815235816600_ref4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ccell.2018.09.007","article-title":"Non-conventional inhibitory CD4+Foxp3\u2013PD-1hi T cells as a biomarker of immune checkpoint blockade activity","volume":"34","author":"Zappasodi","year":"2018","journal-title":"Cancer Cell"},{"key":"2021090815235816600_ref5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","volume":"572","author":"Aizarani","year":"2019","journal-title":"Nature"},{"key":"2021090815235816600_ref6","doi-asserted-by":"crossref","first-page":"eaay8707","DOI":"10.1126\/scitranslmed.aay8707","article-title":"High-dose vitamin C enhances cancer immunotherapy","volume":"12","author":"Magr\u00ec","year":"2020","journal-title":"Sci Transl Med"},{"key":"2021090815235816600_ref7","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJMra1407390","article-title":"Applying synthetic lethality for the selective targeting of cancer","volume":"371","author":"McLornan","year":"2014","journal-title":"N Engl J Med"},{"key":"2021090815235816600_ref8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.celrep.2019.06.067","article-title":"Beyond synthetic lethality: charting the landscape of pairwise gene expression states associated with survival in cancer","volume":"28","author":"Magen","year":"2019","journal-title":"Cell Rep"},{"key":"2021090815235816600_ref9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"2021090815235816600_ref10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat Med"},{"key":"2021090815235816600_ref11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"2021090815235816600_ref12","doi-asserted-by":"crossref","first-page":"D721","DOI":"10.1093\/nar\/gky900","article-title":"CellMarker: a manually curated resource of cell markers in human and mouse","volume":"47","author":"Zhang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021090815235816600_ref13","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N Engl J Med"},{"key":"2021090815235816600_ref14","doi-asserted-by":"crossref","first-page":"ra67","DOI":"10.1126\/scisignal.2001083","article-title":"Synthetic lethal screen of an EGFR-centered network to improve targeted therapies","volume":"3","author":"Astsaturov","year":"2010","journal-title":"Sci Signal"},{"key":"2021090815235816600_ref15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.stemcr.2016.11.008","article-title":"CD59 regulation by SOX2 is required for epithelial cancer stem cells to evade complement surveillance","volume":"8","author":"Chen","year":"2017","journal-title":"Stem Cell Rep"},{"key":"2021090815235816600_ref16","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.4049\/jimmunol.0804243","article-title":"CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?","volume":"182","author":"Sivasankar","year":"2009","journal-title":"J Immunol"},{"key":"2021090815235816600_ref17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41577-019-0131-x","article-title":"Cytokine-mediated communication: a quantitative appraisal of immune complexity","volume":"19","author":"Altan-Bonnet","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2021090815235816600_ref18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular vesicles in cancer: cell-to-cell mediators of metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell"},{"key":"2021090815235816600_ref19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tips.2011.09.004","article-title":"Interleukin-15 biology and its therapeutic implications in cancer","volume":"33","author":"Steel","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"2021090815235816600_ref20","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1158\/0008-5472.CAN-15-1498","article-title":"IL15 and T-cell Stemness in T-cell-based cancer immunotherapy","volume":"75","author":"Pilipow","year":"2015","journal-title":"Cancer Res"},{"key":"2021090815235816600_ref21","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1158\/1078-0432.CCR-10-1966","article-title":"Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model","volume":"16","author":"Yu","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2021090815235816600_ref22","first-page":"11","article-title":"Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial","volume":"68","author":"Pinyol","year":"2018","journal-title":"Gut"},{"key":"2021090815235816600_ref23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"2021090815235816600_ref24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N Engl J Med"},{"key":"2021090815235816600_ref25","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2021090815235816600_ref26","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2021090815235816600_ref27","doi-asserted-by":"crossref","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021090815235816600_ref28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13073-015-0226-3","article-title":"The cancer genome atlas clinical explorer: a web and mobile interface for identifying clinical-genomic driver associations","volume":"7","author":"Lee","year":"2015","journal-title":"Genome Med"},{"key":"2021090815235816600_ref29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.cell.2014.07.027","article-title":"Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality","volume":"158","author":"Jerby-Arnon","year":"2014","journal-title":"Cell"},{"key":"2021090815235816600_ref30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2017.07.005","article-title":"Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening","volume":"170","author":"McDonald","year":"2017","journal-title":"Cell"},{"key":"2021090815235816600_ref31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"2021090815235816600_ref32","doi-asserted-by":"crossref","first-page":"D1011","DOI":"10.1093\/nar\/gkv1108","article-title":"SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets","volume":"44","author":"Guo","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2021090815235816600_ref33","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat Genet"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab058\/40259421\/bbab058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab058\/40259421\/bbab058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T15:24:28Z","timestamp":1631114668000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab058\/6210070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab058","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"type":"print","value":"1467-5463"},{"type":"electronic","value":"1477-4054"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,4,5]]},"article-number":"bbab058"}}